Cargando…

Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology

Adoptive cell therapies (ACTs) have shown transformative efficacy in oncology with five US Food and Drug Administration (FDA) approvals for chimeric antigen receptor (CAR) T‐cell therapies in hematological malignancies, and promising activity for T cell receptor T‐cell therapies in both liquid and s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Weize, Li, Junyi, Liao, Michael Z., Liu, Stephanie N., Yu, Jiajie, Jing, Jing, Kotani, Naoki, Kamen, Lynn, Guelman, Sebastian, Miles, Dale R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786613/ https://www.ncbi.nlm.nih.gov/pubmed/34888856 http://dx.doi.org/10.1002/cpt.2509

Ejemplares similares

Adoptive cell transfer: new perspective treatment in veterinary oncology
por: Bujak, Joanna Katarzyna, et al.
Publicado: (2018)

Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary
por: Shubow, Sophie, et al.
Publicado: (2022)

Tracking the T-cell repertoire after adoptive therapy
por: Watkins, Thomas S, et al.
Publicado: (2017)

Tracking the T-cell repertoire after adoptive therapy
por: Watkins, Thomas S, et al.
Publicado: (2017)

Radiomics in Oncology: A 10-Year Bibliometric Analysis
por: Ding, Haoran, et al.
Publicado: (2021)

Adopting Health Economic Research in Radiation Oncology: A Perspective From Low- or Middle-Income Countries
por: Sinha, Shwetabh, et al.
Publicado: (2022)

Oncology providers’ perspectives on endocrine therapy prescribing and management
por: Wheeler, Stephanie B, et al.
Publicado: (2016)

Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration–Approved Antibody–Drug Conjugates?
por: Liao, Michael Z., et al.
Publicado: (2021)

Macroscopic and microscopic perspectives for adoption of technologies in the USA
por: Carvalho, Alexsandro M., et al.
Publicado: (2020)

Identification of Barriers Preventing Biosimiliar Oncology Medication Adoption
por: Hair, John, et al.
Publicado: (2022)

Translatability of in vitro potency to clinical efficacious exposure: A retrospective analysis of FDA‐approved targeted small molecule oncology drugs
por: Kotani, Naoki, et al.
Publicado: (2023)

Information systems adoption and knowledge performance: An absorptive capacity perspective
por: Liao, Huiyan, et al.
Publicado: (2023)

Quantitative Clinical Pharmacology of T‐Cell Engaging Bispecifics: Current Perspectives and Opportunities
por: Morcos, Peter N., et al.
Publicado: (2020)

Increasing the Adoption and Diffusion of a Novel Pharmacological Therapy That Is Both Mortality Reducing and Cost‐Effective
por: Bergethon, Kristin E., et al.
Publicado: (2019)

Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies
por: Lombard-Banek, Camille, et al.
Publicado: (2020)

Nanoparticles for Enhanced Adoptive T Cell Therapies and Future Perspectives for CNS Tumors
por: Balakrishnan, Preethi Bala, et al.
Publicado: (2021)

Editorial: Expert opinions and perspectives in adoptive cell therapy for cancer: 2022
por: Martín-Antonio, Beatriz
Publicado: (2023)

Una escuela para creer y saber Crecer
por: Guelman de Javkin, Mirta
Publicado: (1998)

T Cells and Adoptive Immunotherapy: Recent Developments and Future Prospects in Gastrointestinal Oncology
por: Amedei, Amedeo, et al.
Publicado: (2011)

Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges
por: Luzzi, Sabino, et al.
Publicado: (2020)

Is it possible to adopt the same oncological approach in urgent surgery for colon cancer?
por: Yoshida, Bruno Yuki, et al.
Publicado: (2022)

Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area
por: Horgan, Denis, et al.
Publicado: (2023)

Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective
por: Fleck, Roman, et al.
Publicado: (2012)

Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
por: Wdowiak, Kamil, et al.
Publicado: (2018)

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network
por: Dias-Santagata, Dora, et al.
Publicado: (2022)

Physician Perspectives on Telemedicine in Radiation Oncology
por: Maroongroge, Sean, et al.
Publicado: (2022)

Editorial: Imaging Technology in Oncology Pharmacological Research
por: Zeng, Qi, et al.
Publicado: (2021)

Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
por: Zhu, Yahui, et al.
Publicado: (2022)

Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology
por: Liu, Stephanie N., et al.
Publicado: (2021)

Adolescent hockey players’ predispositions to adopt sport and exercise behaviours: An ecological perspective
por: Huard Pelletier, Vincent, et al.
Publicado: (2020)

Telehealth Adoption in an Outpatient Oncology Ward: A Best Practice Implementation Project
por: Ventura, Filipa, et al.
Publicado: (2022)

Factors Influencing Residents’ Behavior in Internet Recycling: From the Perspective of the Adoption of New Technology
por: Liu, Tingting, et al.
Publicado: (2022)

Wound healing complications in oncological patients: perspectives for cellular therapy
por: Deptuła, Milena, et al.
Publicado: (2018)

The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
por: Merle, Philippe
Publicado: (2021)

Noise-induced hippocampal damage: potential mechanisms
por: Molina, Sonia Jazmín, et al.
Publicado: (2021)

Perspectives for the Use of Fucoidans in Clinical Oncology
por: Kiselevskiy, Mikhail V., et al.
Publicado: (2022)

Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2020)

Adoption of Pharmacogenomic Testing: A Marketing Perspective
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2021)

A Comment on Ion Channels as Pharmacological Targets in Oncology
por: Becchetti, Andrea, et al.
Publicado: (2008)

Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics
por: Perwitasari, D. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jhm47vadue8rjti5ieteddtmnp